On Cancer

Filter by Tag

In the Lab

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

By Julie Grisham, MS, Science Writer/Editor | Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Tags: Cancer Biology; Cancer Care; Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Finding

A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer

By Allyson Collins, MS, Science Writer/Editor | Wednesday, April 17, 2013

A study led by Memorial Sloan-Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Tags: Cancer Care; PSA Testing; Diagnosis; Screening; Prostate Cancer; Research

Q&A

Department of Surgery Chair Peter Scardino on Smarter Screening for Prostate Cancer

By Esther Napolitano, BS, Science Writer/Editor | Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Tags: Cancer Care; PSA Testing; Diagnosis; Screening; Prostate Cancer

Q&A

Urologist John Mulhall Explains Strategies for Addressing Sexual Health Concerns for Men with Cancer

By Media Staff | Friday, March 8, 2013

Dr. Mulhall, director of Memorial Sloan-Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Tags: Cancer Care; Sexual Health; Bladder Cancer; Prostate Cancer; Testicular Cancer; Counseling & Support; Survivorship

Video

Meet Urologic Cancer Surgeon Raul Parra

By Memorial Sloan-Kettering | Wednesday, March 6, 2013

Dr. Parra, who practices at Memorial Sloan-Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.

Tags: Cancer Care; Bladder Cancer; Surgery; Treatment; Kidney Cancer; Prostate Cancer

Pictured: David Finley & Maria Teresa Ruiz Tsukazan

Feature

Robot-Assisted Surgery at Memorial Sloan-Kettering

By Celia Gittelson, BA | Monday, February 25, 2013

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

Tags: Cancer Care; Robotic Surgery; Surgery; Colorectal Cancer; Esophageal Cancer; Kidney Cancer; Lung Cancer; Prostate Cancer; Uterine Cancer

Honor

Physician-Scientist Charles Sawyers Awarded Breakthrough Prize in Life Sciences

By Media Staff | Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Tags: Drug Discovery; Targeted Therapy; Treatment; Leukemias; Prostate Cancer; Research

Video

Meet Urologic Surgeon Bernard Bochner

By Memorial Sloan-Kettering | Friday, January 11, 2013

Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.

Tags: Cancer Care; Bladder Cancer; Surgery; Kidney Cancer; Prostate Cancer

In the Clinic

Medication Used Before, During, and After Radiation Treatment Helps Men with Prostate Cancer Maintain Overall Sexual Function

By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Tags: Cancer Care; Clinical Trials; Sexual Health; Radiation Therapy; Prostate Cancer

In the Lab

New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

By Eva Kiesler, PhD, Science Writer/Editor | Thursday, November 15, 2012

Researchers at Memorial Sloan-Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Tags: Cancer Biology; Medical Technology; Targeted Therapy; Prostate Cancer; Research

Pictured: Charles Sawyers & Howard Scher

Announcement

Targeted Therapy for Advanced Prostate Cancer Receives FDA Approval

By Memorial Sloan-Kettering | Friday, August 31, 2012

Enzalutamide, a targeted therapy co-invented by a Memorial Sloan-Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.

Tags: Cancer Care; Targeted Therapy; Treatment; Prostate Cancer; Research

Video

Meet Urologic Surgeon Karim Touijer

By Memorial Sloan-Kettering | Tuesday, July 31, 2012

Watch urologic surgeon Karim Touijer discuss our comprehensive approach to cancer care and recent advances in minimally invasive surgery.

Tags: Adult Cancer Care; Cancer Care; Bladder Cancer; Surgery; Kidney Cancer; Prostate Cancer

Perspective

Memorial Sloan-Kettering Experts Maintain That PSA Screening for Prostate Cancer Saves Lives

By Memorial Sloan-Kettering | Friday, June 1, 2012

Memorial Sloan-Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.

Tags: Cancer Care; PSA Testing; Screening; Prostate Cancer

Video

Meet Urologic Surgeon Jonathan Coleman

By Memorial Sloan-Kettering | Monday, May 14, 2012

Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.

Tags: Cancer Care; Surgery; Kidney Cancer; Prostate Cancer

Video

Meet Prostate Cancer Surgeon James Eastham

By Memorial Sloan-Kettering | Monday, April 16, 2012

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Tags: Cancer Care; Surgery; Prostate Cancer